A study of the effectiveness of prophylactic granulocyte colony-stimulating factor (G-CSF) for patients with esophageal cancer who receive DCF therapy.
Phase 2
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000015561
- Lead Sponsor
- Osaka University School of Medicine Gastroenterological Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
1.G-CSF hypersensitivity. 2.Administration of G-CSF within 6 weeks. 3.Infection within 2 weeks. 4.Past history of chemotherapy or radiation therapy. 5.Patients who are pregnant, lactating, with child-bearing potential. 6.Patients who is judged by the investigator to be inappropriate for study participation for any reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method